Related Experiment Videos
Elimination of multicopy plasmid R6K by bleomycin
Antimicrobial Agents and Chemotherapy
|June 1, 1985
Summary
Bleomycin effectively removed high-copy number R6K plasmids from E. coli but not low-copy plasmids. The drug progressively reduced plasmid copy numbers, impacting R6K-encoded beta-lactamase activity.
Area of Science:
- Microbiology
- Molecular Biology
- Genetics
Background:
- Plasmids are extrachromosomal DNA elements crucial for bacterial adaptation.
- Understanding plasmid maintenance and elimination mechanisms is vital in microbiology.
- Different plasmid types (high-copy vs. low-copy) exhibit distinct replication and segregation strategies.
Purpose of the Study:
- To investigate the effect of bleomycin on plasmid elimination in Escherichia coli.
- To determine if bleomycin exhibits selectivity in eliminating plasmids based on copy number.
- To elucidate the mechanism by which bleomycin affects plasmid stability.
Main Methods:
- Treatment of growing Escherichia coli AB1157 cultures with bleomycin.
- Assessing plasmid elimination by monitoring bacterial viability and plasmid presence.
- Quantifying R6K-encoded beta-lactamase activity.
- Measuring the amount of covalently closed R6K plasmid DNA.
Main Results:
- Bleomycin completely eliminated the multicopy plasmid R6K.
- Bleomycin failed to eliminate the low-copy plasmids R1 and R46.
- A progressive reduction in the copy number of R6K was observed.
- Beta-lactamase activity and covalently closed plasmid DNA levels decreased in response to bleomycin.
Conclusions:
- Bleomycin demonstrates selective plasmid elimination activity, targeting multicopy plasmids more effectively.
- The mechanism of bleomycin-induced plasmid loss involves a progressive reduction in plasmid copy number.
- These findings contribute to understanding drug-induced plasmid instability and potential therapeutic strategies.